User:Danielle Bellamy/Herpesviral encephalitis/CrazELearning Peer Review

General info
Danielle Bellamy
 * Whose work are you reviewing?


 * Link to draft you're reviewing:User:Danielle Bellamy/Herpesviral encephalitis
 * Link to the current version of the article (if it exists):Herpes simplex encephalitis

Evaluate the drafted changes
I hope you're having a great day/night Danielle! Here is the peer review for your drafted changes (done section by section):

Signs and Symptoms:
- The addition of first symptoms regarding HSE works well with where it's written because it connects to the previous information. It also added some other symptoms that had not been previously stated in that section.

- You might consider looking into a specific age group to see how often this disease affects them and add it where you see fit (most likely around the added portion).

Lead
Reading this addition in the context of the article, I think it would be helpful to add a little bit more about HSV-2 (at least a sentence or two). What is it caused from on a smaller scale like pathogen-wise. What are the immunocompromised individuals lacking that defends them from this disease? Other than that the addition is well researched and flows well.

Article Body
Signs and Symptoms: I mentioned this previously

Tone and Balance
- The tone of the additions are written well as they do not try to persuade the reader to one side or another. Also, it does not come off as an opinion at any point.

- Blending in the new addition for the signs and symptoms, have you considered adding it near the part where it mentions whom it affects. It would possibly help to make it flow well without confusing the reader.

Other Notes/mentions/suggestions:
- You might consider doing some research into the Epidemiology section of the wiki article because some additions there would be helpful to learn about how often this disease affects populations.

- You could also consider looking into the background context of where this disease originated and or adapted over time.